跳至主要内容
临床试验/NCT00365469
NCT00365469已完成2 期

A Follow-up Study to 5 Years of a Randomized, Double-blinded, Placebo-controlled Study on the Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora

National University Hospital, Singapore2 个研究点 分布在 1 个国家目标入组 253 人开始时间: 2006年5月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
253
试验地点
2
主要终点
Asthma

研究概览

简要总结

The investigators had conducted a double-blind, randomized placebo-controlled clinical trial studying the effects of 6 months probiotics supplementation from birth on allergic disease and sensitization up to 2 years of age. This follow-up study will extend a further 3 years to 5 years of age for assessing the longer term beneficial effects of this form of probiotics intervention on the incidence of allergic disease and sensitization at 5 years of age.

详细描述

Probiotics are helpful bacteria of healthy gut and have shown potential in reducing allergy. A double-blind, randomized placebo-controlled clinical trial studying the effects of 6 months probiotics supplementation from birth on allergic disease and sensitization up to 2 years of age had been conducted. This study aims to assess the longer term beneficial effects of this form of intervention on the incidence of allergic disease and sensitization at 5 years of age by extending the follow-up period.

All children (from original cohort of 253) who completed the initial 2-year visit has been invited to participate. They will be evaluated with monthly phone calls and yearly clinic visits. Allergic sensitization will be assessed with skin prick tests to a panel of allergens.

This project will provide insights into the role of early supplementation of probiotics on the development of the immune system and its effect on allergy. The additional follow-up period is critical for the evaluation of respiratory allergies in the form of clinical asthma, allergic rhinitis and sensitization to inhalant allergens, which tend to develop after 2 years of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • Parents agree to the subject's participation in the study and informed consent has been obtained.
  • The subject has been a participant in the Phase I double-blind, randomized placebo-controlled study and had taken either normal infant formula or formula supplemented with probiotics postnatally for 6 months.
  • The parents are willing to comply with study procedures and are able to keep to scheduled clinic visits.

排除标准

  • The parent is unable /unwilling to comply with procedures.

结局指标

主要结局

Asthma

时间窗: 5 years of age

次要结局

  • Atopic eczema(5 years of age)
  • Allergic Rhinitis(5 years of age)
  • Allergen sensitization(5 years of age)
  • Food Allergy(5 years of age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paediatrics

Dr Marion Aw

National University Hospital, Singapore

研究点 (2)

Loading locations...

相似试验